On the one hand, this microRNA inhibits the Wnt/β-catenin and JAK/STAT signaling pathways, acting as a tumor suppressor and preventing metastasis; on the other hand, it promotes the development of metastases by activating the NF-κB pathway. The gene discussed is NFKB1; the disease is neoplasm.